CoverageForm 410-K10-Q8-K13D13G13F

VATE · Innovate Corp. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · VATE

Income Statement

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$1.25B$1.11B$1.42B$1.64B$1.21B$1.01B
Cost of Revenue$1.05B$898.30M$1.21B$1.42B$1.02B$588.50M
Gross Profit$199.70M$208.80M$216.00M$221.40M$128.40M$417.30M
R&D------
SG&A$153.10M$160.20M$168.00M$180.10M$168.30M$181.10M
Total Operating Expenses-----$1.01B
D&A$30.40M$32.90M$36.00M$42.20M$37.60M$5.90M
Operating Income$28.70M$40.00M$26.50M$13.40M($10.60M)($4.10M)
Interest Expense$89.00M$74.50M$68.20M$52.00M$59.10M$79.40M
Income Tax$2.50M$6.30M$4.50M$900.0K$5.60M$10.50M
Net Income($60.60M)($34.60M)($35.20M)($35.90M)($227.50M)($92.00M)
EPS - Basic($4.84)($3.08)($4.80)($5.30)($29.80)($18.80)
EPS - Diluted($4.84)($3.08)($4.80)($5.30)($29.80)($18.80)

Balance Sheet

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash & Equivalents$112.10M$48.80M$80.80M$80.40M$45.50M$232.30M
Accounts Receivable$241.10M$194.00M$278.40M$254.90M$247.10M$184.70M
Inventory$16.00M$20.80M$22.40M$18.90M$17.00M$9.90M
Accounts Payable------
Current Assets$451.50M$390.90M$517.90M$536.40M$442.60M-
Total Assets$950.10M$891.10M$1.04B$1.15B$1.08B$6.74B
Current Liabilities$1.03B$483.00M$413.80M$417.20M$439.50M-
Long-term Debt------
Total Liabilities$1.17B$1.03B$1.18B$1.18B$1.07B$6.13B
Stockholders' Equity($240.10M)($180.40M)($165.50M)($121.30M)($84.30M)$559.80M
Retained Earnings($582.50M)($521.90M)($487.30M)($452.10M)($416.20M)($188.70M)

Cash Flow

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$146.60M$9.10M$26.50M($9.50M)$27.00M$41.70M
Investing Cash Flow($22.60M)($13.90M)$39.10M($22.50M)($223.20M)$162.30M
Financing Cash Flow($61.20M)($26.50M)($65.30M)$68.10M$4.30M($204.60M)
CapEx$1.20M$19.00M$18.40M$20.70M$24.10M$17.80M
Free Cash Flow$145.40M($9.90M)$8.10M($30.20M)$2.90M$23.90M

Ratios

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Profitability
Gross margin16.0%18.9%15.2%13.5%10.7%41.5%
Operating margin2.3%3.6%1.9%0.8%-0.9%-0.4%
EBITDA margin4.7%6.6%4.4%3.4%2.2%0.2%
Net margin-4.9%-3.1%-2.5%-2.2%-18.9%-9.1%
Free cash flow margin11.7%-0.9%0.6%-1.8%0.2%2.4%
FCF / Net income-2.400.29-0.230.84-0.01-0.26
R&D / Revenue------
SG&A / Revenue12.3%14.5%11.8%11.0%14.0%18.0%
Effective tax rate------
Return on assets-6.4%-3.9%-3.4%-3.1%-21.1%-1.4%
Return on equity25.2%19.2%21.3%29.6%269.9%-16.4%
Return on invested capital------
Liquidity
Current ratio0.440.811.251.291.01-
Quick ratio0.420.771.201.240.97-
Cash ratio0.110.100.200.190.10-
Leverage
Debt / Equity------
Debt / Assets------
Debt / EBITDA------
Interest coverage0.3x0.5x0.4x0.3x-0.2x-0.1x
Equity multiplier-3.96-4.94-6.31-9.49-12.8212.05
Liabilities / Assets1.231.161.131.030.990.91
Efficiency
Asset turnover1.311.241.361.421.120.15
Inventory turnover65.3943.1953.8874.9260.0959.44
Days sales outstanding71d64d71d57d75d67d
Days inventory outstanding6d8d7d5d6d6d
Days payable outstanding------
Cash conversion cycle------
Valuation
P / E------
P / B-----3.0x
P / S0.0x0.0x0.7x0.9x2.4x1.6x
EV / EBITDA-0.9x0.1x14.1x24.6x104.0x789.2x
Growth
Revenue growth (YoY)12.5%-22.2%-13.1%35.9%19.8%-49.3%
Revenue CAGR (3y)-8.7%-2.8%12.3%-6.2%-15.2%-14.9%
Revenue CAGR (5y)4.4%-11.0%-6.4%0.0%-5.0%-2.1%
Gross profit growth (YoY)-4.4%-3.3%-2.4%72.4%-69.2%-25.4%
Operating income growth (YoY)-28.2%50.9%97.8%--158.5%-
Net income growth (YoY)-75.1%1.7%1.9%84.2%-147.3%-192.1%
EPS growth (YoY)-57.1%35.8%9.4%82.2%-58.5%-2585.7%
EPS CAGR (3y)------
EPS CAGR (5y)------
FCF growth (YoY)-----87.9%-65.4%
FCF CAGR (5y)43.5%--51.5%--43.4%-
Book value growth (YoY)-33.1%-9.0%-36.4%-43.9%-60.0%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$1.25B total
Infrastructure Segment$1.21B · 97.1%
Spectrum Segment$23.20M · 1.9%
Life Sciences Segment$12.50M · 1.0%

Product / service

$1.24B total
Commercial Revenue$371.90M · 29.9%
Industrial Revenue$306.60M · 24.6%
Transportation Revenue$192.90M · 15.5%
Healthcare Revenue$173.10M · 13.9%
Government Revenue$128.80M · 10.4%
Broadcast Station Revenue$23.20M · 1.9%
Energy Revenue$13.50M · 1.1%
Leisure Revenue$13.00M · 1.0%
Systems And Consumables Revenue$12.50M · 1.0%
Convention Revenue$8.80M · 0.7%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

0.36
Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

3/9
Weak
  • Net income positive
  • Operating cash flow positive
  • ROA improved YoY
  • Cash flow > net income
  • -Long-term debt decreased
  • Current ratio improved
  • No share dilution
  • Gross margin improved
  • Asset turnover improved

Peer comparison

Same SIC group: Fabricated Structural Metal Products

CompanyRevenue (last FY)Net marginROE
VMI$4.10B8.5%21.5%
ACA$2.88B7.2%7.9%
GIFI---
PRLB--3.2%
TPCS$34.03M-8.1%-31.4%

Comparing INNOVATE Corp. against the 5 most active filers in the same SIC group.

Dividends

$0.00/share trailing 12 months

Ex-datePer share
May 14, 2020$38.9000
Aug 28, 2013$85.0000
Dec 19, 2012$5.0000
Nov 23, 2012$25.0000
Jun 28, 2012$10.0000